Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


‘Do Not Rely On The Brexit Transition Period!’ EC Warns Hesitant Pharma Firms

Executive Summary

Pharmaceutical companies have been urged by the European Commission to press ahead with their contingency planning for Brexit, amid signs some firms are taking a “wait-and-see” approach.


Related Content

UK Biotech Not Impressed By Govt’s Response To MPs’ Brexit Concerns
Brexit Could Make UK A 'Second-Tier State' For Innovative New Drugs, Business Committee Warns
Pharma Backs UK Parliament Report As 'No Deal Brexit' Fears Grow
Industry And Regulators Thrash Out Brexit Concerns At Stakeholder Meeting
EMA Redistributes Responsibility For 370 Drugs Currently Overseen By UK





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts